AKR1B10 is induced by hyperglycaemia and lipopolysaccharide in patients with diabetic nephropathy

Cell Stress and Chaperones

Volumn 19, Issue 2, 2014, Pages 281-287

  Shaw, Nicholas ^a   Yang, Bingmei ^a   Millward, Ann ^a   Demaine, Andrew ^a   Hodgkinson, Andrea ^a  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

Aldose reductase; Aldose reductase family member B10; Diabetic nephropathy; High glucose; Inflammation; Type 1 diabetes

Indexed keywords

AKR1B10 PROTEIN; ALDEHYDE REDUCTASE; GLUCOSE; LIPOPOLYSACCHARIDE; MANNITOL; RETINOIC ACID; SORBINIL; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; YOUNG ADULT;

ADULT; AGED; ALDEHYDE REDUCTASE; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; HYPERGLYCEMIA; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 84896096551     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-013-0455-6     Document Type: Article

References (45)

1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR (2003) Development and progression of nephropathy in type 2 diabetes: observations and modelling from the United Kingdom Prospective Study. Kidney Int 63:225-232 (Pubitemid 35463925)
2. Barnes PJ, Karin M (1997) Nuclear factor-κB a pivotal transcription factor in chronic inflammatory diseases. New Engl J Med 336:1066-1071 (Pubitemid 27163860)
3. Boring L, Gosling J, Chensue S et al (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Investig 100:2552-2561 (Pubitemid 27514895)
4. Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625
5. Ceriello A, Morocutti A, Mercuri F, Quagliaro L, Moro M, Damante G, Viberti GC (2000) Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy. Diabetes 49:2170-2217
6. Chung SS, Chung SK (2001) Aldose reductase in diabetic microvascular complications. Curr Drug Targets 6:211-218
7. Crosas B, Hyndman DJ, Gallego O et al (2003) Human aldose reductase and human small intestine aldose reductase are efficient retinal reductases: consequences for retinoid metabolism. Biochem J 373:973-979 (Pubitemid 36981109)
8. Demaine AG (2003) Polymorphisms of the aldose reductase and susceptibility to diabeticmicrovascular complications. CurrMed Chem 10:1389-1398
9. Devaraj S, Cheung AT, Jialal I et al (2007) Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 56:2790-2796 (Pubitemid 350044923)
10. Duester G (2008) Retinoic acid synthesis and signalling during early organogenesis. Cell 134:921-931
11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26:S5-S20
12. Gallego O, Belyaeva OV, Porte S et al (2006) Comparative functional analysis of human medium-chain dehydrogenases, short chain dehydrogenase/ reductases and aldo-keto reductases with retinoids. Biochem J 399:101-109 (Pubitemid 44505411)
13. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058-1070
14. Guijarro C, Egido J (2001) Transcription factor-κB (NFκB) and renal disease. Kidney Int 59:415-424 (Pubitemid 32157906)
15. Han SY, So GA, Jee YH, Han KH, Kang YS, Kim HK et al (2004) Effect of retinoic acid in experimental diabetic nephropathy. Immunol Cell Biol 82:568-576
16. Hasegawa G, Nakano K, Sawada M, Uno K, Shibayama Y, Ienaga K, Kondo M (1991) Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40:1007-1012
17. Heesom AE, Hibberd ML, Millward BA, Demaine AG (1997) Polymorphism in the 5′-end of the aldose reductase gene is strongly associated with the development of diabetic nephropathy in type 1 diabetes. Diabetes 46:287-291 (Pubitemid 27272263)
18. Hodgkinson AD, Sondergaard KL, Yang B, Cross D, Millward BA, Demaine AG (2001) Aldose reductase expression is induced by hyperglycaemia in diabetic nephropathy. Kidney Int 60:211-218 (Pubitemid 32587556)
19. Hodgkinson AD, Bartlett T, Oates PJ, Millward BA, Demaine AG (2003) The response of antioxidant genes to hyperglycaemia is abnormal in patients with type1 diabetes and diabetic nephropathy. Diabetes 52:846-851 (Pubitemid 36323595)
20. Huang SP, Palla S, Ruzycki P, Varma RA, Harter T, Reddy GB, Petrash JM (2010) Aldo-keto reductases in the eye. J Ophthalmol 2010:1-6
21. Hyndman DJ, Flynn TG (1998) Sequence and expression levels in human tissues of a new member of the aldo-keto reductase family. Biochim Biophys Acta 1399:198-202 (Pubitemid 28410465)
22. Kao YL, Donaghue K, Chan A, Knight J, Silink M (1999) A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes 48:1338-1340 (Pubitemid 29241035)
23. King GL (2008) The role of inflammatory cytokines in diabetes and its complications. J Periodontol 79:1527-1534
24. Liu J, Wen G, Cao D (2009a) Aldo-keto reductase family 1 member B1 inhibitors: old drugs with new perspectives. Recent Pat Anticancer Drug Discov 4:246-253
25. Liu Z, Zhong L, Krishack PA, Robbins S, Xao JX, Zhao Y et al (2009b) Structure and promoter characterisation of aldo-keto reductase family 1 B10 gene. Gene 437:39-44
26. Marshall SM (2004) Recent advances in diabetic nephropathy. Clin Med 4:277-282
27. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, Krolewski AS (2000) Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabetes Med 17:111-118 (Pubitemid 30159045)
28. Na S, Kang B, Chung S et al (1999) Retinoids inhibit interleukin-12 production inmacrophages through physical associations of retinoid X receptor and NFκB. J Biol Chem 274:7674-7680
29. Napoli J (1999) Interactions of retinoid binding proteins and enzymes in retinoid metabolism. Biochim Biophys Acta 1440:139-162
30. Navarro-Gonzalez JF, Mora-Fernandez C (2008) The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol 19:433-442 (Pubitemid 351355386)
31. Rahman I, Gilmour PS, Jimenez LA,MacNeeW(2002) Oxidative stress and TNF-α induce histone acetylation and NFκB/AP-1 activation in alveolar epithelial cells: potentialmechanism in gene transcription in lung inflammation. Mol Cell Biochem 234:239-248 (Pubitemid 34777863)
32. Ramana KV, Srivastava SK (2006) Mediation of aldose reductase in lipopolysaccharide-induced inflammatory signals in mouse peritoneal macrophages. Cytokine 36:115-122 (Pubitemid 46290698)
33. Ramana KV, Fadl AA, Tammali R, Reddy ABM, Chpra AK, Srivastava SK (2006) Aldose reductase mediates the lipopolysaccharide-induced release of inflammatory mediators in RAW264.7 murine macrophages. J Biol Chem 281:33019-33029 (Pubitemid 46036684)
34. Ramana KV, Reddy ABM, Tammali R, Srivastava SK (2007) Aldose reductase mediates endotoxin-induced production of nitric oxide and cytotoxicity in murine macrophages. Free Radic Biol Med 42:1290-1302 (Pubitemid 46428520)
35. Ritz E, Rychlik I, Locatelli F, Halimi S (1999) End stage renal failure in type 2 diabetes. A medical catastrophe of worldwide dimensions. Am J Kidney Dis 34:795-808 (Pubitemid 29521694)
36. Ruiz X, Gallego O, Ardévol A et al (2009) Aldo-keto reductases from the AKR1B1 subfamily: retinoid specificity and control retinoic acid levels. Chem Biol Interact 178:171-177
37. Sassy-Prigent C, Heudes D, Mandet C et al (2000) Early glomerular macrophage recruitment in streptozotocin-induced diabetic rats. Diabetes 49:466-475 (Pubitemid 30131794)
38. Simonson M (1994) Anti-AP-1 activity of all-trans retinoic acid in glomerular mesangial cells. Am J Phys 267:F805-F815
39. Srivastava SK, Ramana KV, Bhatnagar A (2005) Role of Aldose reductase and oxidative damage in diabetes and the consequent potential for therapeutic options. Endocr Rev 26:380-392 (Pubitemid 40691299)
40. Takemura, M., Endo, S., Matsunaga, T., Soda, M., Zhao, H.T., El-Kabbani, O., Tajima, K., Iinuma, M.,Hara, A. (2011) Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolicacid. J Nat Prod 74, 1201-6
41. Tesch G (2008) MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy. Am J Physiol Ren Physiol 294:F697-F701
42. The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986
43. Yang B, Hodgkinson A, Oates PJ, Millward BA, Demaine AG (2008) High glucose induction of DNA-binding activity of the transcription factor NF-κB in patients with diabetic nephropathy. Biochem Biophys Acta 1782:295-302
44. Yerneni KK, Bai W, Khan BV, Medford RM, Natarjan R (1999) Hyperglycaemia induced activation of nuclear transcription factor κB in vascular smooth muscle cells. Diabetes 48:855-864 (Pubitemid 29153087)
45. Zou X, Lu J, Pan C (2000) Effect of polymorphism of (AC)n in the 5′-end of aldose reductase gene in erythrocyte aldose reductase activity in patients with type 2 diabetes mellitus. Clin J Endocrinol Metab 16:346-349